相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease A Randomized Clinical Trial
Tanya Simuni et al.
JAMA NEUROLOGY (2021)
Preparation and optimization of nilotinib self-micro-emulsifying drug delivery systems to enhance oral bioavailability
Ashok Zakkula et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2020)
The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease
Alberto J. Espay et al.
JAMA NEUROLOGY (2020)
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease A Phase 2 Randomized Clinical Trial
Fernando. L. Pagan et al.
JAMA NEUROLOGY (2020)
Computational studies of potent covalent inhibitors on wild type or T790M/L858R mutant epidermal growth factor receptor
Zichao Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
Federico Rossari et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System
Vivek Lawana et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death
R. Wu et al.
CELL DEATH AND DIFFERENTIATION (2016)
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration
Saurav Brahmachari et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The Capable ABL: What Is Its Biological Function?
Jean Y. J. Wang
MOLECULAR AND CELLULAR BIOLOGY (2014)
A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease
Akie Tanabe et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
Senthilkumar S. Karuppagounder et al.
SCIENTIFIC REPORTS (2014)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
c-Abl tyrosine kinase in the DNA damage response: cell death and more
V. Meltser et al.
CELL DEATH AND DIFFERENTIATION (2011)
C-Abl Tyrosine Kinase Signaling: A New Player in AD Tau Pathology
L. D. Estrada et al.
Current Alzheimer Research (2011)
c-Abl in Neurodegenerative Disease
Sarah D. Schlatterer et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease
Syed Z. Imam et al.
JOURNAL OF NEUROSCIENCE (2011)
Fast and Accurate Predictions of Binding Free Energies Using MM-PBSA and MM-GBSA
Giulio Rastelli et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
Han Seok Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Integrated modeling program, applied chemical theory (IMPACT)
JL Banks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Integrin-mediated dendrite branch maintenance requires Abelson (Ab1) family kinases
EMY Moresco et al.
JOURNAL OF NEUROSCIENCE (2005)
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
E Weisberg et al.
CANCER CELL (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Regulation of the C-Abl and Bcr-Abl tyrosine kinases
O Hantschel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Catalase is regulated by ubiquitination and proteosornal degradation. Role of the c-Abl and Arg tyrosine kinases
C Cao et al.
BIOCHEMISTRY (2003)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
分享论文
